Results 1 to 10 of about 19,359,542 (209)

MIS-C and More [PDF]

open access: yesPediatric Infectious Disease, 2023
This PID journal watch provides valuable insights into various aspects of infectious diseases and antibiotic resistance. It highlights the need for continued research, improved diagnostic strategies, and targeted interventions to effectively combat these
Vikram S Kumar
doaj   +2 more sources

Multisystem inflammatory syndrome in children (MIS-C) and “Near MIS-C”: A continuum?

open access: yesFrontiers in Pediatrics, 2023
IntroductionReports of multisystem inflammatory syndrome in children (MIS-C), following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, have been increasing worldwide, with an incidence varying significantly across studies based ...
Sarah Khafaja   +22 more
doaj   +3 more sources

Midterm cardiovascular outcomes in children with MIS-C compared to Kawasaki disease: a multicenter prospective cohort study [PDF]

open access: yesScientific Reports
The overlapping features of multisystem inflammatory syndrome in children (MIS-C) and Kawasaki disease (KD) raise concerns regarding midterm cardiovascular sequelae. We conducted a multicenter prospective cohort study to compare midterm outcomes in MIS-C
Sappaya Khrongsrattha   +12 more
doaj   +2 more sources

Clinical characteristics and short-term outcomes of multisystem inflammatory syndrome in a country with a high prevalence of KD

open access: yesFrontiers in Pediatrics, 2023
BackgroundThe COVID-19 pandemic has spread continuously. Multisystem inflammatory syndrome in children (MIS-C), like Kawasaki disease (KD), is a potentially severe illness in children that appears to be a delayed, post-infectious complication of COVID-19.
Sung Doo You   +3 more
doaj   +1 more source

Global Myocardial Strain in Multisystem Inflammatory Syndrome in Children, Kawasaki Disease, and Healthy Children: A Network Meta-Analysis

open access: yesFrontiers in Pediatrics, 2022
BackgroundNearly 6,000 multisystem inflammatory syndrome in children (MIS-C) have been reported in the United States by November 2021. Left ventricular global myocardial strain has been proved to be one of the best evidence of the diagnostic and ...
Kaiwei Liu, Jiahui Yu, Guang Song
doaj   +1 more source

Treatment and care received by children hospitalized with COVID-19 in a large hospital network in the United States, February 2020 to September 2021.

open access: yesPLoS ONE, 2023
We described care received by hospitalized children with COVID-19 or multi-system inflammatory syndrome (MIS-C) prior to the 2021 COVID-19 Omicron variant surge in the US. We identified hospitalized children 6 years old (54% COVID-19, 70% MIS-C).
Candace C Fuller   +14 more
doaj   +1 more source

Immune Profiles in Multisystem Inflammatory Syndrome in Children with Cardiovascular Abnormalities

open access: yesViruses, 2023
Background: Multisystem inflammatory syndrome in children (MIS-C), a sequela of severe acute respiratory syndrome coronavirus-2 infection (SARS-CoV2), has been progressively reported worldwide, with cardiac involvement being a frequent presentation ...
Nathella Pavan Kumar   +13 more
doaj   +1 more source

Association among COVID-19, multisystem inflammatory syndrome in children, and oral health status [PDF]

open access: yesBrazilian Oral Research, 2023
The pathophysiology of multisystem inflammatory syndrome in children (MIS-C) and associated oral symptoms have not been clarified yet. The aim of the present study was to compare the oral health status of children with MIS-C-associated Coronavirus ...
Gülser KILINÇ   +6 more
doaj   +1 more source

The Youngest Palestinian Case of Multisystem Inflammatory Syndrome in children (MIS-C)

open access: yesمجله كليه طب الكندي, 2022
The multisystem inflammatory syndrome in children (MIS-C) considers a post-infectious immunological response to coronavirus illness (COVID-19) that was originally identified in the United Kingdom and later identified in other countries.
Fawzy Mazen Abunejma   +6 more
doaj   +1 more source

Perbandingan Terapi Tunggal Kortikosteroid Intravena dengan Kombinasi Imunoglobulin dan Kortikosteroid Intravena pada Pasien Multisystem Inflammatory Syndrome in Children

open access: yesSari Pediatri, 2022
Latar belakang. Tata laksana MIS-C saat ini menggunakan imunoglobulin intravena (IVIG) dan kortikosteroid intravena sebagai dua pilar terapi utama. Mekipun demikian, belum terdapat bukti sahih berupa uji klinis acak terkendali mengenai efektivitas terapi
Yogi Prawira, Nicodemus Suwandy
doaj   +1 more source

Home - About - Disclaimer - Privacy